依西美坦|来曲唑、阿那曲唑、依西美坦,乳腺癌内分泌治疗咋选择?( 二 )
1、De Placido S, Gallo C, De Laurentiis M, et al. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial. Lancet Oncol 2018; 19:474.
2、Campos SM, Guastalla JP, Subar M, et al. A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastases. Clin Breast Cancer 2009; 9:39.
【依西美坦|来曲唑、阿那曲唑、依西美坦,乳腺癌内分泌治疗咋选择?】3、Chen S, Lan B, Lv D, et al. Bone safety profile of steroidal aromatase inhibitor in comparison to non-steroidal aromatase inhibitors in postmenopausal women with breast cancer: A network meta-analysis[J]. 2021.
推荐阅读
- 口腔科|拔鱼刺,请不要到口腔科
- 孩子|越来越多的女人怕生孩子,看完这些你就理解她们了……
- 睡眠|睡前玩手机停不下来?过不了多久,你可能要面临三种“难堪”
- 尿毒症|25岁小伙确诊尿毒症,每周4次透析,父母叹息:原来身体早提醒
- 甲状腺|为什么甲状腺有问题的人越来越多?“祸根”不是吃碘盐,而是它
- 早餐|不吃晚餐更健康?久而久之会迎来5个结局,望大家提前知晓
- 预防艾滋病|艾滋病患者福音要来了?mRNA疫苗开始临床试验,治愈或不再是幻想
- 多不饱和脂肪酸|那些长期吃素的人,后来怎么样了?
- 白血病|越来越多孩子患上白血病,提醒家长:孩子有5大异常,需及时排查
- 痛风|痛风,到底是怎么来的?是吃出来的?医生告诉您真相